Total Reports
7
FDA CVM filings
Rabbit /
FDA CVM · 2025 release 7 reports on file
Flemish Giant - FDA Adverse Event Profile
Adverse-event records for Flemish Giant (Rabbit) from the FDA Center for Veterinary Medicine.
Data updated June 2026
The record at a glance
Flemish Giant ranks #461 by report volume among rabbit breeds - 2 of 7 reports (28.6%) recorded a death outcome.
- #461
- most-reported rabbit breed
- 28.6%
- death-coded report share
- 2
- Death - top reaction
- 4.4 yr
- average age at report
Higher volume usually means a more popular breed, not a riskier one, compare against how common the breed is.
Deaths Reported
2
of 7 reports
Death Rate
28.6%
death-coded share
Avg Age at Report
4.4 yr
3.9 kg avg weight
Death-Coded Outcome Share
Flemish Giant death-coded reports 28.6%
Cross-breed median
28.6% of 7 flemish giant reports involved a death outcome.
How to read this number
Read alongside breed popularity, veterinary access, and owner awareness, these shape how many events ever reach the FDA. The comparison line marks the cross-breed median death-coded share (about 4.8%) among breeds with 50 or more reports; values above it suggest higher reporting bias toward severe outcomes, not necessarily higher true mortality.
Average weight at time of report: 3.9 kg (8.6 lbs)
Top Reported Reactions
Death 2
Lethargy (see also Central nervous system depression in 'Neurological') 2
Bradycardia 1
Lack of efficacy - NOS 1
PR-HEART, LESION(S) 1
Most Referenced Drugs
Imidacloprid + Moxidectin 2
Meloxicam 2
Dexmedetomidine Hydrochloride 1
Atipamezole Hydrochloride 1
Ketamine 1
Outcome Breakdown
Outcome Unknown
3 (42.9%)
Died
2 (28.6%)
Recovered/Normal
2 (28.6%)
Gender Distribution
Male 4 (57.1%)
Female 3 (42.9%)
Reports by Year
| Year | Reports | Trend |
|---|---|---|
| 2012 | 1 | |
| 2016 | 2 | |
| 2020 | 3 | |
| 2022 | 1 | |
Flemish Giant Pet Health Insights
Flemish Giant accounts for 7 FDA adverse event reports, ranking #461 by volume among rabbit breeds, with 2 reports (28.6%) coded as a death outcome. Mean age at report: 4.4 years, average weight 3.9 kg (8.6 lbs).
Top reported signs: Death (2), Lethargy (see also Central nervous system depression in 'Neurological') (2), Bradycardia (1). Most-referenced drug: Imidacloprid + Moxidectin (2 reports), followed by Meloxicam (2) and Dexmedetomidine Hydrochloride (1).
Outcome coding on 7 status-recorded reports is dominated by Outcome Unknown (42.9%). Annual submissions ranged 2,012-2,022 across 4 years on file.
Rabbit Breeds With a Similar Report Volume
Frequently Asked Questions
How many FDA adverse event reports involve Flemish Giant? ▼
There are 7 adverse event reports involving Flemish Giant in the FDA database, with 2 reports involving death (28.6% death rate). Flemish Giant ranks #461 by report volume.
What are the most common adverse reactions reported for Flemish Giant? ▼
The most commonly reported adverse reactions for Flemish Giant are Death (2 reports), Lethargy (see also Central nervous system depression in 'Neurological') (2 reports), Bradycardia (1 reports), Lack of efficacy - NOS (1 reports), PR-HEART, LESION(S) (1 reports).
What drugs are most frequently associated with Flemish Giant adverse events? ▼
The drugs most frequently referenced in Flemish Giant adverse event reports are Imidacloprid + Moxidectin (2 reports), Meloxicam (2 reports), Dexmedetomidine Hydrochloride (1 reports), Atipamezole Hydrochloride (1 reports), Ketamine (1 reports).
What is the average age of Flemish Giant in adverse event reports? ▼
The average age of Flemish Giant at the time of adverse event reports is 4.4 years, with an average weight of 3.9 kg (8.6 lbs).
Does a high number of adverse event reports mean Flemish Giant is unhealthy? ▼
No. FDA adverse event reports are voluntarily submitted and do not prove causation. Popular breeds with more veterinary visits tend to have more reports. The data reflects reporting patterns, not actual incidence rates. Always consult a veterinarian for health decisions.
Where does this Flemish Giant safety data come from? ▼
All data comes from the FDA Center for Veterinary Medicine's adverse event reporting system. Pet owners, veterinarians, and manufacturers voluntarily submit reports about adverse events potentially linked to animal drugs and other products.
Compare a breed's report volume against how common the breed is before drawing conclusions. See our methodology for how death rate and rankings are computed.
Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. Breed figures are computed directly from FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.